Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply

Virginia Arechavala-Gomeza, Sebahattin Cirak, Karen Anthony, Jennifer Morgan, Francesco Muntoni

Research output: Contribution to JournalLetterpeer-review


A general catalytic procedure for the cycloaddition of diazo amides to fullerene C60 in the presence of the three-component catalyst, Pd(acac)2–PPh3–Et3Al, has been developed. Depending on the reaction conditions, pyrazolinofullerenes or methanofullerenes are formed.
Original languageEnglish
JournalThe Lancet
Publication statusPublished - 14 Jan 2012


Dive into the research topics of 'Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply'. Together they form a unique fingerprint.

Cite this